Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R ISAACS

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|July 6, 2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudineR M Gulick, J W Mellors, D Havlir, et al.
Scientific Reports|February 12, 2019
Higher abundance of enterovirus A species in the gut of children with islet autoimmunityKi Wook Kim, Jessica L Horton, Chi Nam Ignatius Pang, et al.
JAMA|July 11, 1998
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-upR M Gulick, J W Mellors, D Havlir, et al.
Viruses|February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysGregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
The Journal of Infectious Diseases|April 11, 2001
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 yearsH F Günthard, D V Havlir, S Fiscus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, S A Im, et al.
Proceedings. Biological Sciences|October 12, 2020
Crop production in the USA is frequently limited by a lack of pollinatorsJ R Reilly, D R Artz, D Biddinger, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Open Forum Infectious Diseases|March 1, 2019
Distinct Gut Virome Profile of Pregnant Women With Type 1 Diabetes in the ENDIA StudyKi Wook Kim, Digby W Allen, Thomas Briese, et al.
Pediatric Diabetes|December 5, 2019
Higher frequency of vertebrate-infecting viruses in the gut of infants born to mothers with type 1 diabetesKi Wook Kim, Digby W Allen, Thomas Briese, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|July 6, 2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudineR M Gulick, J W Mellors, D Havlir, et al.
Scientific Reports|February 12, 2019
Higher abundance of enterovirus A species in the gut of children with islet autoimmunityKi Wook Kim, Jessica L Horton, Chi Nam Ignatius Pang, et al.
JAMA|July 11, 1998
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-upR M Gulick, J W Mellors, D Havlir, et al.
Viruses|February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysGregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
The Journal of Infectious Diseases|April 11, 2001
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 yearsH F Günthard, D V Havlir, S Fiscus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, S A Im, et al.
Proceedings. Biological Sciences|October 12, 2020
Crop production in the USA is frequently limited by a lack of pollinatorsJ R Reilly, D R Artz, D Biddinger, et al.
Plos Medicine|July 6, 2021
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variantsFiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
Open Forum Infectious Diseases|March 1, 2019
Distinct Gut Virome Profile of Pregnant Women With Type 1 Diabetes in the ENDIA StudyKi Wook Kim, Digby W Allen, Thomas Briese, et al.
Pediatric Diabetes|December 5, 2019
Higher frequency of vertebrate-infecting viruses in the gut of infants born to mothers with type 1 diabetesKi Wook Kim, Digby W Allen, Thomas Briese, et al.
Pageof 13